The validity of clinical risk score for patients undergoing liver resection for colorectal metastases

Hepato-Gastroenterology

Volumn 56, Issue 94-95, 2009, Pages 1452-1458

  Ivanecz, Arpad ^a   Potrc, Stojan ^a   Horvat, Matjaz ^a   Jagric, Tomaz ^a   Gadzijev, Eldar ^a  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

Colorectal cancer; Liver metastases; Prognostic factors; Surgery; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SIZE; CLINICAL RISK SCORE; COLORECTAL CANCER; DISEASE FREE INTERVAL; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL RATE; TREATMENT RESPONSE; VALIDITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 71949105577     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F, et al: One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991; 78: 797-801.
2. Scheele J, Stang R, Altendorf-Hofmann A, Paul M: Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
3. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaign D, Kunstlinger F, Levi F, Bismuth F: Five-year survival following hepatic resection after neo-adjuvant therapy for nonresectable colorectal liver metastases. Ann Surg Oncol 2001; 8:347-353. (Pubitemid 32422861)
4. Choti MA, Sitzmann JV, Tiburi MF, et al: Trends in long-term survival following hver resection for hepatic colorectal metastases. Ann Surg 2002; 235:759-766
5. Vauthey JN, Pawlik TM, Abdalla EK, et al: Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 2004; 239:722-732
6. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, et al: Extension of the fronteries of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000; 231: 487-499 (Pubitemid 30185854)
7. Cady B, Jenkins RL, Steele GD Jr, Lewis WD, Stone MD, McDermott WV, et al: Surgical margin in hepatic resection for colorectal metastases: a critical and improvable determinant of outcome. Ann Surg 1998; 227: 566-571. (Pubitemid 28363275)
8. Nordlinger B, Guiget M, Vaillant JC, Balladur P, Boudjema K, Bachelier P, et al: Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection. Cancer 1996; 771: 1254-1262 (Pubitemid 26102322)
9. Tomizawa N, Ohwada S, Ogawa T, Tanahashi Y, Koyama T, Hamada K, Kawate S, Sunose Y: Factors affecting the prognosis of anatomical hver resection for liver metastases from colorectal cancer. Hepatogastroenterology 2006; 53:89-93. (Pubitemid 43287401)
10. Liska V, Treska V, Holubec L, Kormunda S, Skalicky T, Sutnar A, Topolcan O: Recurrence of colorectal liver metastases after surgical treatment: multifactorial study. Hepatogastroenterology 2007; 54:1741-1744
11. Fong Y, Fortner J, Sun RL, Brennen MF, Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-321.
12. Mala T, Bohler G, Mathisen O, et al: Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 2002; 26:1348-1353
13. Mann CD, Metcalfe MS, Leopardi LN, Maddern GJ: The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg 2004; 139: 1168-1172
14. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Brit J Surg 2006; 93:872-878 (Pubitemid 44035261)
15. FujiiY, Shimada H, Endo I, Takeda K, Takahashi K, Tanaka K, Togo S: Improvement of prognosis for colorectal metastases by major hepatectomy after portal vein embolization. Hepatogastroenterology 2005; 52: 1792-1794. (Pubitemid 41745632)
16. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, et al: Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations. Surgery 2000; 127:512-519 (Pubitemid 30257509)
17. Abdalla EK, Vauthey JN, Ellias LM, et al: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-827
18. Nordlinger B, Sorbye H, Collette L, et al: Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. ASCO Annual Meeting Proceedings, J Clin Oncol 2007; 25(18S):LBA5.
19. Goldstein NS, Sandford W, Coffey M, et al: Lymph node recovery from colorectal resection specimens removed for adenocarcinoma.Trends over time recommendation for a minimum number of lymph nodes to be recovered. Am. J. Clin. Pathol. 1996; 106:209-217
20. Pawlik TM, Abdalla EK, EllisLM, Vauthey JN, Curley SA: Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastro Surg 2006; 10:240-248
21. Weber SM, Janargin WR, De Matteo RP, Blumgart LH, Fong Y: Survival after resection of multiple colorectal metastases. Ann Surg Oncol 2000; 7: 643-650. (Pubitemid 30764729)
22. Pawlik TM, Choti MA: Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases. Current Colorectal Cancer Reports 2006; 2:85-93.